化療病人使用針灸是否能減輕化療引起的周邊神經病變?Using acupuncture to relieve chemotherapy – induced peripheral neuropathy among chemotherapy patients

984 5 164         DOI:doi.org/10.30131/TWNA_EBHC_Library.DB_2021110018A/Text

2022-09-22 已刊登
綜 整 預防/治療/介入類型

作  者

王甄薇 張雅淳* 傅美玲 古雪貞

文章類別

A 類:實證健康照護綜整

問題類型

治療/預防性問題

健康狀況

腫瘤醫學 (Oncology)  

治療/介入措施

其他(Others) - 針灸

專長類別

傳統與輔助醫療

中文關鍵詞

#針灸 #化學治療 #周邊神經病變

英文關鍵詞

#Acupuncture # chemotherapy # peripheral neuropathy

機構名稱

台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院

申請單位

六病房

中文摘要

形成臨床提問:
化療是癌症病人重要治療方式,使用神經毒性化療藥物病人約30-80%有周邊神經病變困擾,周邊神經傳導損傷之臨床症狀表現為刺痛或灼痛、麻木或感覺異常等,會影響病人日常活動及生活品質,嚴重時需減少化療劑量或停止治療;而緩解周邊神經病變的處置或藥物有限,故期望透過文獻搜尋與分析,進一步瞭解針灸療法是否能減輕化療引起的周邊神經病變,期望藉由此次的探討,提供病人有效的處置,進而提升癌症病人的照護及生活品質,提供臨床上醫護人員照護之參考。
文獻搜尋的方法與分析:
以PICO及MeSH term建立關鍵字及同義字,利用布林邏輯OR及AND,搜尋Cochrane Library、UpToDate、PubMed、Embase、CINAHL、華藝、台灣論文期刊索引資料庫,共搜尋713篇文章,刪除重複、與研究主題不符文章,最後選定一篇系統性文獻統合分析,一篇隨機對照試驗文獻納入評讀。
文獻的品質評讀:
運用CASP檢核表及2011年英國Oxford Center的證據等級標準進行文獻品質評析,兩篇文獻等級分別為Level I及Level II。 1.Jin et al.(2020): 本篇統合分析將19篇RCT文章納入分析,共1174位個案,在CIPN治療中,針灸常用的穴位是LI4、LI11、ST36、EX10和EX-UE 9,與藥物和假針灸相比,針灸顯著提高了CIPN的總有效率(RR為1.63,95%CI 1.38至1.93, p<.00001, I2=0%),對神經傳導速度的恢復(95%CI 2.06至2.44, p <.00001) 、癌症治療的功能評估-神經毒性的分數(95% CI −2.03至−1.62, p <.00001)和改善疼痛(95%CI -1.71至-1.58, p <.00001)有很好的作用(Level I)。 2.Iravani et al.(2020): 針對40名CIPN症狀超過3個月的病人,實驗組每週3次針灸治療,持續4週,對照組每天服用300mg vitamin B1和300 mg gabapentin 持續4週,於第2週、第4週、第8週評估病人疼痛強度和感覺神經病分級量表隨時間顯著下降(均p<.001)、在治療結束時(第4週)和第8週後實驗組對治療的總體滿意度較高(分別為p < .01和p < .001)、神經傳導(NCS)明顯改善(p <.05),且沒有與針灸治療相關不良事件(Level II)。
結果、結論與建議:
綜合上述文獻發現針灸治療對於CIPN病人神經傳導速度的恢復及改善疼痛療效顯著且安全,未違反倫理,耗費成本低,可做為CIPN的病人多一種選擇機會及治療方式。但由於研究中包括的樣本量少、沒有一致性的對照組、缺乏長期觀察,可能影響有效性評估的準確性,故應謹慎看待結果,建議未來可做較長期及大型的研究。盼藉由針灸治療能協助病人及早改善化學治療引發周邊神經病變的症狀,提升病人生活品質及臨床照護滿意度。

英文摘要

Ask an answerable question (PICO):
Chemotherapy is an important treatment for cancer patients. About 30-80% of patients who use neurotoxic chemotherapy drugs suffer from peripheral neuropathy, such as peripheral numbness, burning, and tingling, which affects the patient’s daily activities, quality of life, and causes emotional distress. In severe cases, reducing the drug dosage or even ceasing chemotherapy is necessary; however, the potential solutions that can alleviate these symptoms are limited. Therefore, we hope that through literature review and analysis, we can determine is a better word to use whether acupuncture therapy can alleviate chemotherapy-induced peripheral neuropathy. We can further discuss providing patients with effective symptom treatment, avoiding permanent functional damage, reducing the impact of symptoms on daily activities, improving quality of life and quality of care of cancer patients, and providing clinical references for medical staff.
The Method and Analysis of Literature Review:
Data collection was based on the empirical PICO method, using MeSh term, Entry Terms and synonyms, the keyword included Problem -Chemotherapy, Interventions - Acupuncture, Outcome - Chemotherapy-Induced Peripheral Neuropathy. We used Boolean logic OR and AND to search in the Cochrane Library, UpToDate, PubMed, Embase, CINAHL , Airiti Library, and Taiwan Periodical Literature System databases, and adjusted the search settings appropriately. A total of 713 articles were reviewed is a better word, and duplicated papers, titles, and abstracts not consistent with the research topic were deleted. Two articles that matched the topic were included in the review. One of them was a systematic review, meta-analysis, and the other was a randomized controlled trial articles in 2020.
Critical Appraisal:
Using the CASP checklist and the 2011 Oxford Center's standard of evidence to evaluate the quality of the articles, the two reviewed articles are rated LevelⅠand LevelⅡ. 1. Jin et al. (2020): In this meta-analysis, 19 RCTs with 1174 patients were enrolled. The most common acupoints for CIPN are LI4, LI11, ST36, EX10, and EX-UE 9. Compared with medicine and sham acupuncture, acupuncture significantly increased the total effective rate of CIPN (RR, 1.63; 95% CI, 1.38 to 1.93; p<.00001; I2=0%), restored nerve conduction velocity (95% CI, 2.06 to 2.44; p<.00001), functional assessment of cancer treatment-neurotoxicity (FACT-NTX) score (95% CI, −2.03 to −1.62; p<.00001) and pain improvement (95% CI, -1.71 to -1.58; p<.00001) (LevelⅠ). There are parentheses within parentheses in these sentences that require accurate punctuation, I would advise you look up which punctuation marks to use specifically for medical research. 2. Iravani et al. (2020): For 40 patients with CIPN symptoms over 3 months, the experimental group was treated with acupuncture 3 times a week for 4 weeks. The control group took 300mg vitamin B1 and 300 mg gabapentin every day for 4 weeks. The pain intensity (NRS) and sensory neuropathy grading scale (NCI-CTCAE) were evaluated in the second, fourth, and eighth weeks, and both were significantly decreased over time (both p<.001). At the end of the treatment (4 week later), and after 8 weeks, the experimental group was found to have higher overall satisfaction with the treatment (p<.01 and p<.001, respectively), improving nerve conduction (NCS) (p<.05), and no adverse events related to acupuncture treatment ( LevelⅡ).
Results, Conclusions and Recommendations:
Based on both articles above, acupuncture treatment was found to be safe and improved the recovery of nerve conduction velocity and pain in CIPN patients. There are no ethical issues, can lower the cost of treatment, can reduce the patient’s discomfort arising from peripheral neuropathy, and avoid prolonged hospitalization, which would reduce medical expenses. Acupuncture can be used as an additional choice of treatment for CIPN patients. However, due to the small sample size, the lack of consistent control groups, and the lack of long-term follow up, the results of these studies regarding the effectiveness of acupuncture for CIPN patients should be treated with caution. Future studies should focus on longer follow up and be larger scaled. We hoped that acupuncture treatment can help patients improve the symptoms of peripheral neuropathy caused by chemotherapy more efficiently, providing better cares, improve their quality of life and clinical care satisfaction.